ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 335766 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 335766; 2) Community: the network communities that were significantly associated with the response to NSC 335766; 3) Molecule: the relationships between components within communities and NSC 335766; 4) MDR: the compounds that were significantly associated with the NSC 335766.

NSC Compound Enrichment Correlation
NSC 139021 1-(2-Thiazolylazo)-2-naphthol 0.0339770934764508 0.64780605
NSC 145219 Null 0.0339770934764508 0.22158644
NSC 153325 Null 0.0339770934764508 0.40537238
NSC 172599 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.0339770934764508 0.27516881
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0339770934764508 0.28600735
NSC 237677 Null 0.0339770934764508 0.34059297
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.0339770934764508 0.44645873
NSC 3053 Actinomycin D 0.0339770934764508 0.45744336
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0339770934764508 -0.089102655
NSC 381866 BAFILOMYCIN DERIV. 0.0339770934764516 0.37738781
Total:145  Current:108    [First] [Prev] [Next] [Last]